Dostinex 0.5 Mg 2 Tablets

Dostinex 0.5 Mg 2 Tablets

Description:

Dostinex 0.5 mg is a prescription oral medicine containing cabergoline, a long-acting dopamine agonist and potent prolactin inhibitor. It is primarily used to treat hyperprolactinemia (elevated prolactin levels), which can cause menstrual disturbances, infertility, and abnormal breast milk production in both women and men. By stimulating dopamine D2 receptors in the pituitary gland, Dostinex reduces prolactin secretion, helping restore hormonal balance and improve associated symptoms. Each pack contains 2 scored tablets for accurate dosing as prescribed by a healthcare professional.

Indications:

• Treatment of hyperprolactinemic disorders (elevated prolactin levels), whether idiopathic or due to prolactin-secreting pituitary adenomas (prolactinomas).
• Management of symptoms related to hyperprolactinemia such as amenorrhea, oligomenorrhea, anovulation, galactorrhea, and infertility in women.
• Management of hyperprolactinemia-associated symptoms in men, including decreased libido, impotence, and infertility.
• Adjunctive or alternative therapy in conditions where reduction of prolactin is clinically required, as determined by a specialist.
• May be used in the management of Parkinsonian syndrome (as per prescribing information) as monotherapy in early stages or as an adjunct to levodopa in advanced disease, when prescribed by a neurologist.

Active Ingredients / Key Components:

• Cabergoline – 0.5 mg per tablet.
• Excipients (tablet base, fillers, binders, etc.) – exact composition and concentrations , please check the product leaflet or the manufacturer’s official website; please refer to the official package leaflet for full excipient list.

Dosage & Administration / How to Use:

• Dostinex is for oral use only and must be taken exactly as prescribed by your doctor.
• For hyperprolactinemia, treatment usually starts with a low dose (for example 0.25 mg twice weekly or 0.5 mg once weekly), then may be adjusted gradually based on prolactin levels and clinical response. The exact regimen must be determined by the physician.
• Tablets may be taken with food to help reduce gastrointestinal side effects such as nausea.
• Swallow the tablet with a glass of water. The tablet is usually scored to allow division into smaller doses if needed.
• Do not exceed the prescribed weekly dose. Your doctor may schedule regular blood tests to monitor prolactin levels and adjust the dose.
• If you miss a dose, take it as soon as you remember unless it is almost time for your next scheduled dose. Do not double the dose to make up for a missed one.
• Do not stop taking Dostinex abruptly without consulting your doctor, as symptoms may return or worsen.

Clinical Benefits:

• Effectively lowers elevated prolactin levels by directly stimulating dopamine D2 receptors in the pituitary gland.
• Helps restore normal menstrual cycles and ovulation in women with hyperprolactinemia-related menstrual disorders and infertility.
• Reduces or resolves galactorrhea (abnormal breast milk production) in both women and men.
• Improves sexual function and fertility parameters in men with hyperprolactinemia-associated hypogonadism.
• Long-acting effect allows for convenient once- or twice-weekly dosing compared with some other prolactin-lowering therapies.
• May improve quality of life by alleviating symptoms such as headaches, visual disturbances, and hormonal imbalance associated with prolactinomas (as evaluated and monitored by a specialist).

Warnings & Contraindications:

• Use only under medical supervision. Dostinex is a potent prescription medicine and is not for self-medication.
• Contraindicated in patients with known hypersensitivity to cabergoline, other ergot derivatives, or any of the excipients.
• Contraindicated in patients with a history of pulmonary, pericardial, or retroperitoneal fibrotic disorders, or with evidence of cardiac valvulopathy as determined by appropriate imaging (e.g. echocardiography).
• Use with extreme caution in patients with severe cardiovascular disease, hypotension or uncontrolled hypertension, liver impairment, or a history of serious psychiatric disorders (especially psychosis).
• May cause somnolence and sudden sleep onset; patients should be cautious when driving or operating machinery until they know how the medicine affects them.
• Regular monitoring (including blood pressure, prolactin levels, and, when indicated, echocardiography) may be required during long-term treatment.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Cabergoline is generally not recommended during pregnancy unless clearly needed, and breastfeeding is usually not advised while taking this medicine.
• Inform your doctor about all other medicines you are taking, especially other dopamine agonists, antipsychotics, antihypertensives, macrolide antibiotics, or ergot derivatives, due to potential interactions.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision and prescription.
• Keep out of reach of children.

Side Effects:

• Common side effects may include nausea, vomiting, stomach discomfort, constipation, dizziness, headache, fatigue, and low blood pressure (especially postural hypotension).
• Other possible side effects: flushing, palpitations, peripheral edema, mood changes, depression, nervousness, or sleep disturbances.
• Rare but serious adverse effects may include cardiac valvulopathy, fibrotic reactions (pulmonary, pericardial, retroperitoneal), severe psychiatric symptoms (hallucinations, psychosis), or sudden sleep onset.
• Stop the medicine and seek immediate medical attention if you experience chest pain, persistent shortness of breath, swelling of legs, severe abdominal or back pain, severe headache, visual changes, or signs of allergic reaction (rash, itching, swelling, difficulty breathing).
• Report any unusual or persistent side effects to your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date stated on the package. Store at the temperature conditions specified in the official leaflet; do not use if tablets appear damaged or discolored.

Specifications:

• Strength: 0.5 mg cabergoline per tablet.
• Form: Oral tablets.
• Pack size: 2 tablets per pack.
• Intended use: Prescription medicine for the treatment of hyperprolactinemia and related disorders, under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.